What is the official website of geneOmbio Technologies ?

The official website of geneOmbio Technologies is http://www.geneombiotechnologies.com.

What is geneOmbio Technologies's cybersecurity risk score?

geneOmbio Technologies has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has geneOmbio Technologies experienced?

According to Rankiteo, geneOmbio Technologies currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has geneOmbio Technologies been affected by any supply chain cyber incidents ?

According to Rankiteo, geneOmbio Technologies has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does geneOmbio Technologies have SOC 2 Type 1 certification ?

According to Rankiteo, geneOmbio Technologies is not certified under SOC 2 Type 1.

Does geneOmbio Technologies have SOC 2 Type 2 certification ?

According to Rankiteo, geneOmbio Technologies does not hold a SOC 2 Type 2 certification.

Does geneOmbio Technologies comply with GDPR ?

According to Rankiteo, geneOmbio Technologies is not listed as GDPR compliant.

Does geneOmbio Technologies have PCI DSS certification ?

According to Rankiteo, geneOmbio Technologies does not currently maintain PCI DSS compliance.

Does geneOmbio Technologies comply with HIPAA ?

According to Rankiteo, geneOmbio Technologies is not compliant with HIPAA regulations.

Does geneOmbio Technologies have ISO 27001 certification ?

According to Rankiteo,geneOmbio Technologies is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does geneOmbio Technologies operate in ?

geneOmbio Technologies operates primarily in the Biotechnology industry.

How many employees does geneOmbio Technologies have ?

geneOmbio Technologies employs approximately 64 people worldwide.

Does geneOmbio Technologies own any subsidiaries ?

geneOmbio Technologies presently has no subsidiaries across any sectors.

How many LinkedIn followers does geneOmbio Technologies have ?

geneOmbio Technologies's official LinkedIn profile has approximately 12,988 followers.

Does geneOmbio Technologies have a Crunchbase profile ?

No, geneOmbio Technologies does not have a profile on Crunchbase.

Does geneOmbio Technologies have a LinkedIn profile ?

Yes, geneOmbio Technologies maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/geneombio-technologies.

How many cybersecurity incidents has geneOmbio Technologies experienced ?

As of October 15, 2026, Rankiteo reports that geneOmbio Technologies has not experienced any cybersecurity incidents.

How many peer or competitor companies does geneOmbio Technologies have ?

geneOmbio Technologies has an estimated 1,078 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

geneOmbio Technologies

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

geneOmbio Technologies Vendor Cyber Rating & Cyber Score

geneombiotechnologies.com

Add Your Compliance Badge

geneOmbio Technologies Pvt. Ltd. ISO/IEC 17025:2017 & ISO 15189:2022 certified | Pune, India GeneOmbio is a precision-genomics company that turns molecular insight into measurable value for the life-science, pharma, and biopharma sectors. Why partners choose us • Comprehensive infrastructure Automated fluorescent DNA sequencers • high-throughput robotised real-time and multiplex-PCR platforms • NGS pipelines • PCR-qPCR workstations • gradient & conventional thermal cyclers • BSL-2 biosafety suites - all under GLP/GMP digital data control. • Molecular Diagnostic Services 60 single- & multiplex PCR assays validated for infectious diseases, congenital disorders, and pharmacogenetic markers, with Sanger and NGS confirmation options. • Pharma

geneOmbio Technologies

geneOmbio Technologies CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

geneOmbio Technologies Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for geneOmbio Technologies

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for geneOmbio Technologies in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for geneOmbio Technologies in 2026.

Incident Types geneOmbio Technologies vs Biotechnology Industry Avg (This Year)

No incidents recorded for geneOmbio Technologies in 2026.

Incident History - geneOmbio Technologies (X = Date, Y = Severity)

Loading…

SUBSIDIARY

geneOmbio Technologies Subsidiaries

Parent Company

geneOmbio Technologies

Biotechnology

Website: http://www.geneombiotechnologies.com

Company Size: 64

No subsidiary data available for this company.

Loading…

geneOmbio Technologies Similar Companies

Regeneron

regeneron.com

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Loading…

NEWS

geneOmbio Technologies CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-110873

SUMMARY

Heym from 0.0.55 before 0.0.121 contains a privilege escalation vulnerability that allows shared collaborators to overwrite a workflow's error_workflow_id because the field is missing from OWNER_ONLY_EXECUTION_FIELDS. Attackers can point the error workflow to their own workflow with an HTTP node, and when the parent workflow errors the owner's decrypted credentials are injected and exfiltrated.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-110872

SUMMARY

Nodemailer from 3.0.0 before 10.0.10 contains a quadratic complexity denial of service vulnerability in the SMTP client reply parser in SMTPConnection._onData and isPartialResponse. A malicious SMTP server or on-path attacker can stream continuation lines without a completion line before authentication, blocking the Node.js event loop and exhausting memory.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.2

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2026-110871

SUMMARY

Nodemailer from 3.0.0 before 10.0.10 contains a denial of service vulnerability in MessageParser.parseHeaders that allows users to exhaust CPU through quadratic header unfolding. Attackers can supply large recipient lists or long headers that fold into tens of thousands of continuation lines, blocking the Node.js event loop during DKIM signing.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-110870

SUMMARY

Nodemailer from 3.0.0 before 10.0.13 contains an improper input validation vulnerability in its address parser that fails to strip RFC 5322 comments inside angle-bracket addresses. Attackers can supply recipients like a display name with a parenthesized comment in the domain, so illegal characters reach envelope.to and RCPT TO, causing rejected delivery or parser interpretation conflicts that bypass domain allow-lists.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-110869

SUMMARY

Nodemailer 3.0.0 before 10.0.13 has a regular expression denial of service in SMTPConnection._actionEHLO, whose four AUTH mechanism detection regexes contain overlapping whitespace sub-patterns that backtrack quadratically. A malicious or man-in-the-middle SMTP server can reply to EHLO with 250-AUTH, a long whitespace run and a non-matching token, blocking the Node.js event loop for tens of seconds to hours before authentication.

Published

Date2026-10-14

Updated

Date2026-10-14

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

geneOmbio Technologies Vendor Cyber Rating & Cyber Score

geneOmbio Technologies A.I CyberSecurity Scoring

geneOmbio Technologies CyberSecurity News & History

geneOmbio Technologies Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for geneOmbio Technologies

Incidents vs Biotechnology Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types geneOmbio Technologies vs Biotechnology Industry Avg (This Year)

Incident History - geneOmbio Technologies (X = Date, Y = Severity)

geneOmbio Technologies Subsidiaries

Parent Company

geneOmbio Technologies

geneOmbio Technologies Similar Companies

Regeneron

geneOmbio Technologies CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

geneOmbio Technologies CyberSecurity News & History

geneOmbio Technologies Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for geneOmbio Technologies

Incidents vs Biotechnology Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types geneOmbio Technologies vs Biotechnology Industry Avg (This Year)

Incident History - geneOmbio Technologies (X = Date, Y = Severity)

geneOmbio Technologies Subsidiaries

Parent Company

geneOmbio Technologies

geneOmbio Technologies Similar Companies

Regeneron

geneOmbio Technologies CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo